Procept BioRobotics Target Price

See Procept BioRobotics's analyst price targets ($23) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$19.3

Average Target Price

$23.20

20.2% upside

10 analysts in the last 4 months

High: $30 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-05	Truist Financial	$21	8.8% upside
2026-08-05	Evercore ISI	$23	19.2% upside
2026-08-05	Robert W. Baird	$20	3.6% upside
2026-08-05	Piper Sandler	$25	29.5% upside
2026-08-05	Wells FargoNathan Treybeck	$19	1.6% downside
2026-08-05	JefferiesMichael Sarcone	$20	3.6% upside
2026-07-28	UBS	$20	3.6% upside
2026-07-02	Truist Financial	$25	29.5% upside
2026-06-24	Evercore ISIVijay Kumar	$30	55.4% upside
2026-06-11	Leerink Partners	$29	50.3% upside
2026-04-30	Piper SandlerMatt O'Brien	$35	81.3% upside
2026-02-27	Truist FinancialRichard Newitter	$30	55.4% upside
2026-02-26	Wells FargoNathan Treybeck	$34	76.2% upside
2025-12-18	Truist FinancialRichard Newitter	$47	143.5% upside
2025-12-12	UBSDanielle Antalffy	$62	221.2% upside
2025-12-02	Morgan StanleyPatrick Wood	$51	164.2% upside
2025-11-05	Piper SandlerMatt O'Brien	$50	159.1% upside
2025-11-05	Leerink PartnersMike Kratky	$55	185% upside
2025-11-05	Wells Fargo	$51	164.2% upside
2025-10-15	Truist Financial	$50	159.1% upside
2025-09-02	OppenheimerSuraj Kalia	$60	210.9% upside
2024-12-02	Morgan StanleyPatrick Wood	$105	444% upside
2024-10-29	Truist FinancialRichard Newitter	$105	444% upside
2024-09-03	Truist FinancialRichard Newitter	$95	392.2% upside
2024-07-16	Truist FinancialRichard Newitter	$79	309.3% upside
2024-05-06	Piper SandlerMatt O'Brien	$75	288.6% upside
2024-05-02	Truist FinancialRichard Newitter	$72	273.1% upside
2022-09-02	Wells FargoNathan Treybeck	$49	153.9% upside

Procept BioRobotics (PRCT) FAQ

The latest target price for PRCT is $23. Investors often review this figure alongside Procept BioRobotics's historical trend and sector peers before judging valuation or financial health.

Procept BioRobotics trades near $19.3 while the consensus target sits at $23 (20.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting PRCT's target price ($23), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Procept BioRobotics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.